Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Saunders

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Mapping cell-cell fusion at single-cell resolutionAndrea L Gardner, Lan Zheng, Kennedy Howland, et al.
The Pediatric Infectious Disease Journal|June 20, 2014
Diagnosis and treatment of tuberculosis among children at an HIV care program in Dar es Salaam, TanzaniaLisa V Adams, Thomas McQuillan, Helga E Naburi, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.
Cancers|November 25, 2023
Setup Uncertainty of Pediatric Brain Tumor Patients Receiving Proton Therapy: A Prospective StudyJared Becksfort, Jinsoo Uh, Andrew Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid TumorsJames Spicer, Aurélien Marabelle, Jean-Francois Baurain, et al.
Blood Advances|July 11, 2024
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphomaThomas Witzig, Lubomir Sokol, Won Seog Kim, et al.
Cancer Research|June 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR ActivityAlison E Smith, Stacia Chan, Zhiyong Wang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Mapping cell-cell fusion at single-cell resolutionAndrea L Gardner, Lan Zheng, Kennedy Howland, et al.
The Pediatric Infectious Disease Journal|June 20, 2014
Diagnosis and treatment of tuberculosis among children at an HIV care program in Dar es Salaam, TanzaniaLisa V Adams, Thomas McQuillan, Helga E Naburi, et al.
Cancer Chemotherapy and Pharmacology|December 12, 2012
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyEric Van Den Neste, Bruno Cazin, Ann Janssens, et al.
Cancers|November 25, 2023
Setup Uncertainty of Pediatric Brain Tumor Patients Receiving Proton Therapy: A Prospective StudyJared Becksfort, Jinsoo Uh, Andrew Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid TumorsJames Spicer, Aurélien Marabelle, Jean-Francois Baurain, et al.
Blood Advances|July 11, 2024
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphomaThomas Witzig, Lubomir Sokol, Won Seog Kim, et al.
Cancer Research|June 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR ActivityAlison E Smith, Stacia Chan, Zhiyong Wang, et al.
Pageof 2